Loading clinical trials...
Loading clinical trials...
The primary objectives of this study are to evaluate the antiviral efficacy, safety, and tolerability of therapy with sofosbuvir/velpatasvir (SOF/VEL) fixed-dose combination (FDC) in adults with chron...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gilead Sciences
NCT06718530 · Hepatitis C Virus Infection
NCT05361603 · Hepatitis C, Transmission, Intravenous Drug Abuser, and more
NCT05975216 · Hepatitis C Virus Infection
NCT05071261 · Hepatitis C Virus Infection
NCT05906459 · Hepatitis C Virus Infection
Chiba University Hospital
Chiba
Fukui-ken Saiseikai Hospital
Fukui
Japanese Red Cross Fukuoka Hospital
Fukuoka
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions